NCM · Financial Statements
IN8bio, Inc. (INAB) Financial Statements
$1.34
NCM: INAB
Market Cap $12.85M
Overview Financials Dividend IN8bio, Inc. most recently reported annual revenue of $0, net profit of $-19.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $0 $0 $0 $0 $0 Operating Profit $-15.0M $-29.0M $-30.0M $-30.0M $-20.0M Net Profit $-15.0M $-29.0M $-30.0M $-30.0M $-19.0M EPS $-23.41 $-40.81 $-30.14 $-17.05 $-4.44 Op Margin — — — — —
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $42.0M $33.0M $34.0M $21.0M $32.0M Total Liabilities $4.0M $10.0M $9.0M $6.0M $5.0M Cash $37.0M $18.0M $21.0M $11.0M $27.0M Borrowings $2.0M $6.0M $5.0M $5.0M $3.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-14.0M $-24.0M $-23.0M $-24.0M $-13.0M Investing Cash Flow $-1.0M $-7.0M $-1.0M $0 $0 Financing Cash Flow $-3.0M $0 $0 $5.0M $0 Net Cash Flow $19.0M $-19.0M $3.0M $-10.0M $16.0M Free Cash Flow $-14.0M $-28.0M $-24.0M $-24.0M $-13.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA 0.14 FCF Yield -108.73% Quick Ratio 8.21 Interest Coverage 0.00 Return 1Y -33.49% Return 3Y -97.04% Return 5Y —
Screens featuring this stock